Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 1 de 1
Filtrar
Mais filtros

Base de dados
Ano de publicação
Tipo de documento
Intervalo de ano de publicação
1.
Elife ; 72018 07 25.
Artigo em Inglês | MEDLINE | ID: mdl-30039798

RESUMO

The early-life intestinal microbiota plays a key role in shaping host immune system development. We found that a single early-life antibiotic course (1PAT) accelerated type 1 diabetes (T1D) development in male NOD mice. The single course had deep and persistent effects on the intestinal microbiome, leading to altered cecal, hepatic, and serum metabolites. The exposure elicited sex-specific effects on chromatin states in the ileum and liver and perturbed ileal gene expression, altering normal maturational patterns. The global signature changes included specific genes controlling both innate and adaptive immunity. Microbiome analysis revealed four taxa each that potentially protect against or accelerate T1D onset, that were linked in a network model to specific differences in ileal gene expression. This simplified animal model reveals multiple potential pathways to understand pathogenesis by which early-life gut microbiome perturbations alter a global suite of intestinal responses, contributing to the accelerated and enhanced T1D development.


Assuntos
Antibacterianos/efeitos adversos , Diabetes Mellitus Tipo 1/imunologia , Microbioma Gastrointestinal/imunologia , Imunidade Inata/efeitos dos fármacos , Imunidade Adaptativa/efeitos dos fármacos , Animais , Antibacterianos/imunologia , Diabetes Mellitus Tipo 1/microbiologia , Diabetes Mellitus Tipo 1/patologia , Feminino , Microbioma Gastrointestinal/efeitos dos fármacos , Íleo/imunologia , Íleo/microbiologia , Imunidade Inata/imunologia , Intestinos/microbiologia , Camundongos , Camundongos Endogâmicos NOD , Microbiota/efeitos dos fármacos , Microbiota/imunologia
SELEÇÃO DE REFERÊNCIAS
Detalhe da pesquisa